Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
NZSG – Johnson & Johnson Research Fellowship 2026
Tuesday August 25, 2026
Calling all NZSG members – applications are now open for the prestigious Research Fellowship funded by Johnson & Johnson...
ANZGITA – Samoa 2026
Tuesday August 25, 2026
This years’ ANZGITA visit to Samoa was a special milestone as it marked the 10th anniversary of ANZGITA training and tea...